TURN-KEY

Aligning R&D with business and IP 

BUILT

BY INNOVATORS 

FOR INNOVATORS

Dalriada’s Turn-Key Drug Discovery model is specifically designed to provide ultimate support for semi-virtual lean biotechs developing small molecule therapies. 

We uniquely integrate internal R&D, end-to-end program management, business and IP support to unlock the most rapid and agile program execution and ultimately the fastest route to the clinic.

​

We focus on value building for each client and partner and conduct all programs with an R&D-to-milestone approach. Drawing experience from Pharma, Biotech, VC, and Academia, Dalriada’s team equally understands both the science and business needs, which allows for a seamless collaboration with the biotech client or a fully autonomous project execution.

THREE PILLARS

OF TURN-KEY   

MODEL

1

2

3

Through unique integration of R&D, business and IP, we unlock the most agile program execution and rapid advancement of the asset

• MedChem

• In vitro pharmacology

• Cell Biology

• PK / ADME

OUR TRACK RECORD

WHY PARTNER

WITH US

Proprietary cascade

for targeted covalent

inhibitors discovery

and development

Most Rapid and Agile Program Execution

• Focused teams built for each project within <2 weeks
   

• Internal integrated chemistry-biology R&D significantly accelerates the
  hit-to-lead and lead optimization cycles
   

• Shift the team size and composition any time as the project advances or expands

Accelerated

Value Building

IP-focused Approach

• Ongoing Pharma, VC, and biotech
  insight into each project
   

• R&D-to-milestone approach – from program planning to passing due diligence
   

• Jump-starting and expanding pipelines

• Scientific team trained
  by top legal firms
   

• Experience with conservative and highly aggressive IP strategies

Customized Solution

for Every Project

Innovation-driven

Autonomous

Project Execution

• Dedicated R&D-business-IP team built for each project
   

• Development of custom programs and screening cascades tailored specifically
  to the project and business needs

• Up-to-date with science
   

• Custom assay development for most innovative projects
   

• Monitoring and adapting to recent industry developments
   

• Implementing break-through innovation

• Projects executed fully
  autonomously by Dalriada or in a seamless collaboration with a client 

TOP

STANDARDS

OUR CLIENTS